Transient Expression of mRNA Lipid Nanoparticle-based Chimeric Antigen Receptors for Immunotherapy

CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle PlatformПодробнее

RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.Подробнее

"Ionizable lipid nanoparticles advance translation of mRNA-based vaccines & therapy” - Gairdner WeekПодробнее

The use of RNA vaccines to promote CAR-T stimulation in solid tumorsПодробнее

Webinar: Lipid nanoparticle LNP synthesis and CAR-T applicationПодробнее

Insights on Lipid Nanoparticle Delivery and Scalable Microfluidic ManufacturingПодробнее

GenVoy-ILM™ T Cell Kit for mRNA Promotional VideoПодробнее

Transient Expression of mRNA-LNP-based Chimeric Antigen Receptors for Safe ImmunotherapyПодробнее

A platform for automated functionalization of lipid nanoparticles for CAR T cell therapyПодробнее

Accelerating T Cell Therapy ResearchПодробнее

Lipid nanoparticle (LNP) production for mRNA-based vaccinesПодробнее

Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid NanoparticlesПодробнее

Cationic lipids offer new possibilities in liposome and LNP engineering for RNA therapeuticsПодробнее

In vivo mRNA Delivery to Antigen-specific T cells by Antigen-presenting NanoparticlesПодробнее

Lipid Nanoparticle Delivery Technology for siRNA and mRNA TherapeuticsПодробнее

mRNA delivery for the development of T cell therapies: the potential of polydopamine nanosensitizersПодробнее

What are Lipid Nanoparticles (LNP)?Подробнее

The quest for next-generation lipid nanoparticles for cell-specific delivery of mRNAПодробнее

07 mRNA as gene editing application for cell therapyПодробнее